{"title":"用于药物发现的植物性天然产物:目前的方法和前景。","authors":"Noohi Nasim, Inavolu Sriram Sandeep, Sujata Mohanty","doi":"10.1007/s13237-022-00405-3","DOIUrl":null,"url":null,"abstract":"<p><p>Nature has abundant source of drugs that need to be identified/purified for use as essential biologics, either individually or in combination in the modern medical field. These drugs are divided into small bio-molecules, plant-made biologics, and a recently introduced third category known as phytopharmaceutical drugs. The development of phytopharmaceutical medicines is based on the ethnopharmacological approach, which relies on the traditional medicine system. The concept of 'one-disease one-target drug' is becoming less popular, and the use of plant extracts, fractions, and molecules is the new paradigm that holds promising scope to formulate appropriate drugs. This led to discovering a new concept known as polypharmacology, where natural products from varying sources can engage with multiple human physiology targets. This article summarizes different approaches for phytopharmaceutical drug development and discusses the progress in systems biology and computational tools for identifying drug targets. We review the existing drug delivery methods to facilitate the efficient delivery of drugs to the targets. In addition, we describe different analytical techniques for the authentication and fingerprinting of plant materials. Finally, we highlight the role of biopharming in developing plant-based biologics.</p>","PeriodicalId":53176,"journal":{"name":"Nucleus (India)","volume":" ","pages":"399-411"},"PeriodicalIF":2.1000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579558/pdf/","citationCount":"25","resultStr":"{\"title\":\"Plant-derived natural products for drug discovery: current approaches and prospects.\",\"authors\":\"Noohi Nasim, Inavolu Sriram Sandeep, Sujata Mohanty\",\"doi\":\"10.1007/s13237-022-00405-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Nature has abundant source of drugs that need to be identified/purified for use as essential biologics, either individually or in combination in the modern medical field. These drugs are divided into small bio-molecules, plant-made biologics, and a recently introduced third category known as phytopharmaceutical drugs. The development of phytopharmaceutical medicines is based on the ethnopharmacological approach, which relies on the traditional medicine system. The concept of 'one-disease one-target drug' is becoming less popular, and the use of plant extracts, fractions, and molecules is the new paradigm that holds promising scope to formulate appropriate drugs. This led to discovering a new concept known as polypharmacology, where natural products from varying sources can engage with multiple human physiology targets. This article summarizes different approaches for phytopharmaceutical drug development and discusses the progress in systems biology and computational tools for identifying drug targets. We review the existing drug delivery methods to facilitate the efficient delivery of drugs to the targets. In addition, we describe different analytical techniques for the authentication and fingerprinting of plant materials. Finally, we highlight the role of biopharming in developing plant-based biologics.</p>\",\"PeriodicalId\":53176,\"journal\":{\"name\":\"Nucleus (India)\",\"volume\":\" \",\"pages\":\"399-411\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579558/pdf/\",\"citationCount\":\"25\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nucleus (India)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s13237-022-00405-3\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/10/18 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"CELL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nucleus (India)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13237-022-00405-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/10/18 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
Plant-derived natural products for drug discovery: current approaches and prospects.
Nature has abundant source of drugs that need to be identified/purified for use as essential biologics, either individually or in combination in the modern medical field. These drugs are divided into small bio-molecules, plant-made biologics, and a recently introduced third category known as phytopharmaceutical drugs. The development of phytopharmaceutical medicines is based on the ethnopharmacological approach, which relies on the traditional medicine system. The concept of 'one-disease one-target drug' is becoming less popular, and the use of plant extracts, fractions, and molecules is the new paradigm that holds promising scope to formulate appropriate drugs. This led to discovering a new concept known as polypharmacology, where natural products from varying sources can engage with multiple human physiology targets. This article summarizes different approaches for phytopharmaceutical drug development and discusses the progress in systems biology and computational tools for identifying drug targets. We review the existing drug delivery methods to facilitate the efficient delivery of drugs to the targets. In addition, we describe different analytical techniques for the authentication and fingerprinting of plant materials. Finally, we highlight the role of biopharming in developing plant-based biologics.
Nucleus (India)Biochemistry, Genetics and Molecular Biology-Genetics
CiteScore
3.90
自引率
0.00%
发文量
26
期刊介绍:
The journal publishes original, peer-reviewed articles on new and significant advances in all aspects of cell and chromosome research. Timely and substantial articles in the areas of cell biology, genetic toxicology, chromosome evolution, cytogenetics; molecular-, population- and evolutionary genetics; epigenetics; developmental and stress biology; transcriptomics, structural and functional genomics, proteomics, metabolomics, integrated omics and use of tools of bioinformatics in the areas stated herein. Studies demonstrating the use of modern approaches such as genome editing to address technological problems and/or biological questions pertaining to the research areas mentioned above are encouraged. However, the studies should be conducted with appropriate scientific rigor in the design, conduct, validity, and interpretation of results to ensure reliability and reproducibility of the data presented. The papers must be written concisely and be of interest to a broad audience.
The journal also publishes comprehensive reviews on current developments and future trends in cell and chromosome research. Such articles should be authoritative, covering all the aspects of a chosen topic, and serve as a resource for students, researchers, and multidisciplinary audience. Authors are welcome to contact the Editor-in-Chief to discuss their topic of interest while preparing a prospective review article.
Thematic special issues on cutting edge research in the development of the above stated areas are periodically published by the journal. Articles for such issues are commissioned by the respective topic editor/s.